Wei Chang

Research Associate II, Experimental Immunology at Allen Institute for Immunology
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Languages
  • Mandarin (Traditional Chinese) Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Research Associate II, Experimental Immunology
      • Dec 2020 - Present

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Research Assistant in Cancer Immunotherapy
      • Oct 2018 - Nov 2020

      - Assist in the development of RNA CAR-T constructs and bispecific antibody constructs for solid tumor cancers - Transfect HEK293, produce and purify proteins for immunization and produce therapeutic antibodies - Excellent experience with molecular biology laboratory techniques, such as gel electrophoresis, DNA cloning, PCR, ELISA for making CAR-T constructs. Experience with flow cytometry. - Maintenance of laboratory and inventory database - Assist in the development of RNA CAR-T constructs and bispecific antibody constructs for solid tumor cancers - Transfect HEK293, produce and purify proteins for immunization and produce therapeutic antibodies - Excellent experience with molecular biology laboratory techniques, such as gel electrophoresis, DNA cloning, PCR, ELISA for making CAR-T constructs. Experience with flow cytometry. - Maintenance of laboratory and inventory database

    • Higher Education
    • 100 - 200 Employee
    • Research Intern
      • Jun 2017 - Aug 2017

      Worked under department of Biomedical Science - Assisted in PEGylation of nanoparticles and humanized bispecific antibodies for imaging and treatment of chronic lymphocytic leukemia. - Participated in developing antibody lock that prevents the generation of neutralizing anti-PEG antibodies which may affect efficacy of PEGylated therapeutics Worked under department of Biomedical Science - Assisted in PEGylation of nanoparticles and humanized bispecific antibodies for imaging and treatment of chronic lymphocytic leukemia. - Participated in developing antibody lock that prevents the generation of neutralizing anti-PEG antibodies which may affect efficacy of PEGylated therapeutics

    • United States
    • Higher Education
    • 400 - 500 Employee
    • Teaching Assistant / Tutor
      • Aug 2015 - Jun 2016

Education

  • University of Washington
    Bachelor of Science - BS, Biochemistry
    2016 - 2018

Community

You need to have a working account to view this content. Click here to join now